ICD-10 Code D34: Benign neoplasm of thyroid gland

Key Takeaways

ICD-10 Code D34 is a billable ICD-10-CM diagnosis code for benign neoplasm of thyroid gland, valid for FY2026 (October 1, 2025 through September 30, 2026).

Thyroid adenoma and follicular adenoma map to D34 through the ICD-10-CM Alphabetic Index, not a formal tabular note; D34 also carries a ‘use additional code’ instruction for functional activity, and must not be confused with thyroid goiter or malignant thyroid neoplasms, which use separate codes.

The ICD-9-CM equivalent is code 226; D34 falls under block D10-D36 within Chapter 2 (Neoplasms, C00-D49) and must not be confused with C73 (malignant thyroid neoplasm).

Practice management software like Pabau supports accurate ICD-10 code entry, documentation workflows, and HIPAA-compliant billing for thyroid and endocrine diagnoses.

ICD-10 Code D34 is the billable diagnosis code for benign neoplasm of thyroid gland.

It covers the non-cancerous thyroid growths coders classify as thyroid adenoma or follicular adenoma, distinct from C73, the malignant thyroid code.

This reference covers billable status, the conditions that map to D34, the codes not to confuse it with, the ICD-9 crosswalk, MS-DRG mapping, and the documentation requirements that keep D34 claims clean.

The 2026 edition of ICD-10-CM D34 became effective on October 1, 2025. It is valid for all HIPAA-covered transaction submissions through September 30, 2026, per CMS ICD-10 coding guidance.

ICD-10 Code D34: Code details at a glance

D34 is a billable, specific ICD-10-CM code. It carries a single-level code structure with no sub-codes beneath it. The table below summarizes the key reference data coders need at the point of claim submission.

D34 has no child codes. There is no D34.8, no D34.9, and no decimal extension of any kind. When a thyroid neoplasm is confirmed as benign through pathology or imaging, D34 is the correct and final code selection.

No further specificity is available within the ICD-10-CM tabular list for this diagnosis, so a claim edit that rejects D34 for a missing fourth character is misconfigured.

What does D34 mean clinically?

A benign neoplasm of the thyroid gland is an abnormal but non-malignant growth arising from thyroid tissue. These growths do not invade adjacent structures or metastasize, which is what separates a benign neoplasm of thyroid from the malignant thyroid tumors coded to C73.

Clinically, the most common presentations coded under D34 include thyroid adenomas discovered incidentally on imaging, follicular adenomas confirmed on fine-needle aspiration cytology (FNAC), and benign thyroid nodules with pathological confirmation. The WHO ICD-10 browser classifies D34 under the broad neoplasms chapter alongside other benign endocrine gland tumors.

D34 is used in both outpatient and inpatient settings. In outpatient endocrinology and primary care, it documents the diagnosis following ultrasound or biopsy findings. In inpatient settings, it may appear as a secondary diagnosis when a thyroid adenoma is managed alongside another primary condition.

Conditions that map to D34: Thyroid adenoma ICD-10 and follicular adenoma

D34 has no formal “Applicable To” note in the ICD-10-CM tabular list.

Thyroid adenoma and follicular adenoma map to D34 through the ICD-10-CM Alphabetic Index instead, where these terms are listed as approximate synonyms for benign neoplasm of the thyroid gland. Coders frequently search for thyroid adenoma ICD-10 and follicular adenoma coding; both point to D34 for this reason.

D34 does carry one real tabular instruction, shown in the table above: use additional code to identify any functional activity. This applies when the adenoma is also producing excess thyroid hormone.

• Adenoma of thyroid – a benign epithelial tumor arising from the thyroid parenchyma
• Follicular adenoma of thyroid gland – the most common benign thyroid neoplasm, encapsulated, arising from follicular epithelium

Any documentation using these clinical terms maps directly to D34. If the operative or pathology report states “follicular adenoma” without malignant features, D34 is the appropriate code. Pathology confirmation is strongly preferred over imaging-only diagnosis when selecting this code for inpatient claims.

Codes not to confuse with D34

D34 does not carry an Excludes1 note in the FY2026 ICD-10-CM tabular list.

The codes below are not officially excluded by a coding convention. They are separate diagnoses that get mixed up with D34 because they involve the same anatomy or similar-sounding documentation, so getting the distinction right is a matter of correct code selection rather than a tabular rule.

The codes coders most often confuse with D34 involve the thyroid but represent distinct pathological entities:

• Thyroid goiter (E04.-) – goiter represents diffuse or nodular enlargement due to non-neoplastic causes (iodine deficiency, autoimmune thyroiditis); it is not a neoplasm and does not code to D34
• Malignant neoplasm of thyroid gland (C73) – any confirmed malignancy assigns to C73, not D34; the two describe different pathology and should never be reported for the same finding
• Congenital anomalies of thyroid – developmental conditions such as thyroglossal cyst code to Q89.2 series, not D34

When documentation is ambiguous (for example, “thyroid mass, rule out malignancy”), coders should query the treating clinician rather than defaulting to either D34 or C73. ICD-10-CM guidelines do not permit coding an unconfirmed malignancy as confirmed in outpatient settings.

Benign vs. malignant thyroid neoplasm: Choosing the right ICD-10 code

The distinction between D34 and C73 is the single most consequential coding decision for thyroid neoplasm encounters. Assigning C73 incorrectly triggers oncology care pathways, alters insurance risk classification, and affects patient records permanently. Accurate ICD-10 code selection depends entirely on the documentation source: the pathology report, the cytology result, or the clinician’s confirmed diagnosis.

Never assign D34 when pathology is pending. In the outpatient setting, an unconfirmed thyroid mass takes the symptom or finding code (for example, E04.1 for a non-toxic single thyroid nodule) until pathology confirms the benign nature of the growth.

Code hierarchy: Where ICD-10 Code D34 fits in ICD-10-CM

Understanding the parent-child hierarchy helps coders navigate adjacent codes and confirm they have selected the most specific option available. The ICD-10-CM classification system organizes all diagnosis codes into chapters, blocks, and individual codes.

• Chapter 2: Neoplasms (C00-D49) – covers all neoplastic conditions, benign through malignant
• Block D10-D36: Benign neoplasms, except benign neuroendocrine tumors – the parent block for D34
• D34: Benign neoplasm of thyroid gland – the specific billable code; no sub-codes exist beneath D34

The block D10-D36 covers benign neoplasms of the mouth, major salivary glands, and other organs including endocrine glands. D34 sits alongside D35 (benign neoplasm of other and unspecified endocrine glands) within this block, which is where a parathyroid adenoma (D35.1) belongs. When the site is the thyroid, D34 is always the correct selection over D35.

Chapter 2 also includes the neighboring D37-D48 block for neoplasms of uncertain behavior, such as D43.2, which applies only when pathology cannot yet confirm whether a growth is benign or malignant.

ICD-9-CM to ICD-10 crosswalk: Code 226 to D34

Practices transitioning legacy data or reconciling historical claims need the ICD-9-CM crosswalk. The ResDAC crosswalk guidance provides context on how ICD-9-to-ICD-10 crosswalks apply to Medicare claims data.

This is a one-to-one crosswalk. ICD-9-CM 226 maps exclusively to D34 with no alternative ICD-10-CM options. Practices running reports on historical thyroid adenoma coding should use 226 as the ICD-9 filter and D34 as the ICD-10 equivalent when reconciling pre- and post-2015 claims data.

Manage ICD-10 codes without the paperwork bottleneck

Pabau's claims management software keeps ICD-10 code workflows clean, documentation complete, and HIPAA-compliant billing on track – so your team spends less time chasing denials.

Book a demo

MS-DRG mapping for D34

When D34 appears on an inpatient claim, the CMS MS-DRG (Medicare Severity Diagnosis Related Group) grouper uses it alongside the principal diagnosis and any procedures performed to assign a DRG for hospital payment. The AAPC ICD-10-CM code lookup provides MS-DRG mapping data for D34 based on the current CMS grouper tables.

D34 typically appears as a secondary or comorbidity diagnosis on inpatient claims. The DRG assignment depends primarily on the principal diagnosis and any surgical procedure, such as a thyroid lobectomy coded under the relevant ICD-10-PCS code.

When thyroid surgery is performed for a benign adenoma, the case typically groups to the Thyroid, Parathyroid and Thyroglossal Procedures range (MS-DRG 625-627) under MDC 10, Diseases and Disorders of the Endocrine, Nutritional and Metabolic System. Verify specific DRG numbers against the current CMS MS-DRG grouper at the time of submission, since assignments update annually with each fiscal year release.

Related ICD-10-CM codes for thyroid conditions

Coders working with thyroid conditions need the full map of adjacent codes to avoid miscoding. The table below covers the ICD-10 codes most frequently confused with D34, including the non-neoplastic thyroid conditions that show up in the same clinical context.

Coding tips and documentation requirements for D34

Three documentation failures drive the majority of D34 claim denials and audit flags. Addressing each one at the point of clinical note entry prevents downstream billing delays.

Pathology confirmation

D34 requires confirmation that the growth is a neoplasm, not simply a nodule or enlargement. Acceptable documentation sources include: surgical pathology report stating “benign follicular adenoma” or “adenoma of thyroid without invasion,” FNAC report with Bethesda Category II classification (benign), or cytology report explicitly stating benign thyroid tissue.

Ultrasound findings alone (for example, “hypoechoic thyroid nodule”) do not support D34. Use E04.1 until pathology is available.

When imaging guidance is used to mark a nodule for biopsy or excision, the procedure is billed separately under a code such as CPT 10035, alongside the diagnosis code rather than in place of it. The CDC/NCHS ICD-10-CM web tool confirms that D34’s conditions are pathologically defined, not imaging-defined.

Additional codes that may be needed

D34 is a standalone billable code, but some encounters warrant additional diagnosis codes. Document any functional thyroid disorder separately. Add E03.9 when the adenoma coexists with hypothyroidism, E05.- for hyperthyroidism, or E06.5 for chronic thyroiditis, since these represent distinct clinical problems beyond the structural neoplasm.

Practices offering functional medicine, where hormone panels are part of routine monitoring, run into this pairing often and should treat it as a standard cross-check rather than an afterthought.

For surgical encounters, the digital clinical documentation should capture the procedure code separately (ICD-10-PCS or CPT as applicable) alongside D34 as the diagnosis driving the surgical intervention. Payers require the relationship between the diagnosis and the procedure to be explicit in the claim.

Outpatient vs. inpatient sequencing

In the outpatient setting, D34 is the first-listed diagnosis when the thyroid adenoma is the reason for the encounter.

Inpatient sequencing follows a different rule. ICD-10-CM Official Guidelines require the condition established after study to be the principal diagnosis. When a thyroid lobectomy is performed, D34 typically functions as that principal diagnosis and drives the admission.

When the admission is for another condition, such as cardiovascular disease, and the thyroid adenoma is an incidental finding, D34 codes as a secondary diagnosis.

How Pabau supports accurate diagnostic code management

Claim denials linked to diagnostic coding errors cost practices significant recovery time. Practice management software like Pabau gives coding teams a structured claims management workflow for attaching ICD-10 codes at the point of service, so clinical documentation and the submitted claim stay in sync instead of drifting apart.

For thyroid and endocrine cases, the workflow matters as much as the code. Pabau’s clinical record management system keeps pathology reports, imaging notes, and clinician documentation in one place, so the coder has everything needed to confirm D34 versus an alternative code before submission. Built-in HIPAA-compliant documentation workflows mean sensitive diagnosis data is handled securely throughout the billing cycle.

Practices managing multi-specialty or high-volume endocrine coding, including metabolic health practices tracking thyroid function alongside other hormonal markers, can use Pabau’s practice management software to flag incomplete documentation before claims leave the system, reducing first-pass denial rates for codes like D34 where pathology confirmation is required.

Protecting patient data security throughout the diagnostic coding and billing process is built into the platform’s core architecture.

The bottom line on coding D34

ICD-10 Code D34 is a straightforward billable code when documentation is in order. The failures happen at the edges: submitting before pathology returns, conflating a non-toxic nodule with a confirmed adenoma, or confusing D34 with the thyroid goiter codes it is routinely mixed up with.

Pabau’s claims management software links pathology documentation to claim submissions, keeping D34 cases clean from the first clinical note to the final remittance. A standardized endocrinology intake template gives the coding team a consistent starting point for capturing the clinical detail these claims depend on.

Continue your research

Need structured documentation tools for endocrine diagnoses? Digital clinical documentation forms helps practices capture pathology-linked consent and clinical notes in a single compliant workflow.

Coding hypertension with an endocrine cause? ICD-10 Code I15.2 covers hypertension secondary to endocrine disorders, including hyperthyroidism, and how to sequence it correctly.

Working with manifestation codes for endocrine disease? ICD-10 code E35 explains how to sequence disorders of endocrine glands caused by another documented disease.

Frequently asked questions